Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 October 2019 | Story Ruan Bruwer | Photo Gallo Images
Lappies Labuschagne
Lappies Labuschagné got his first rugby contract with the Cheetahs after impressing for the Shimlas. He is now playing for Japan – the first Shimla to do so.

Former Shimla Lappies Labuschagné made his ex-coach Jaco Swanepoel proud when he was recently included in the Japan Rugby World Cup (RWC) squad.

Labuschagné, made his debut for Japan on 28 September as captain shortly before the tournament, which is currently under way there, then led Japan to a historic win over Ireland, the world’s fourth-ranked team.


Labuschagné has been playing his rugby in Japan since 2016. Previously, he played for the Shimlas between 2009 and 2012 and captained the team in 2012. At that time, Swanepoel was the head coach of the Shimlas. 

“I’m extremely glad that he got his chance to play in the World Cup, just to prove that he can compete at that level. It was wonderful to see the leadership we knew he had on Saturday,” Swanepoel said.

He believes Labuschagné was unlucky not to have played for the Springboks. In 2013, he was called up to the South African squad, but failed to force his way into the congested Springbok back row. 

“Subjectivity in team selection was the reason that he wasn’t considered. He deserved to be selected and he worked extremely hard. I don’t know of a player who worked harder than him. Nobody wanted to work out with him in the gymnasium, because he always put in extra effort. That made him special.”

Swanepoel describes Labuschagné as a “very special person”.

“Lappies the human being is perhaps a little bit better than Lappies the rugby player.”  

“Hopefully we can get a Japan rugby jersey from him to display in the Shimla room soon,” Swanepoel added.

Labuschagné isn’t the only former Kovsie at the RWC. In the Springbok management team, Rassie Erasmus (head coach), Jacques Nienaber (defence coach), and Vivian Verwant (physiotherapist) are also former Kovsies.


News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept